Inari Medical saw the highest growth of 1.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.19% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Inari Medical’s patent filings and grants. Buy the databook here.
Inari Medical has been focused on protecting inventions in United States(US) with 14 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 60% filings and 92% grants. The United States(US), World Intellectual Property Organization(WIPO), Australia(AU), and European Patent Office(EPO) patent Office are among the top ten patent offices where Inari Medical is filings its patents. Among the top granted patent authorities, Inari Medical has 92% of its grants in United States(US) and 8% in Australia(AU).
Olympus and Boston Scientific could be the strongest competitors for Inari Medical
In terms of grant share, Inari Medical stands in sixth position among its competitors. Olympus and Boston Scientific secured the top positions according to recent patent publication data.
General surgery devices related patents lead Inari Medical portfolio followed by cardiovascular devices
Inari Medical has highest number of patents in general surgery devices followed by cardiovascular devices.
For comprehensive analysis of Inari Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.